Danisco Partners with Arboris on Pine-Derived Phytosterols

The global phytosterol market, currently estimated at more than USD 300 million and growing an annual 7-9%, will receive a significant boost through this agreement due to the complementary capabilities of the two companies.

4/4/2011 --- Danisco has signed a long-term agreement with US-based company Arboris to market their pine-derived phytosterols. Phytosterols are naturally occurring compounds with proven ability to reduce cholesterol. Backed by over 200 human intervention studies, regulatory authorities globally have recognised phytosterols for their cardiovascular health benefit.

Both companies are very excited about the opportunities specifically presented in the developing health and nutrition arena.

“While markets in Europe and, to some extent, the US have seen good penetration, many parts of Asia, Eastern Europe and South America have yet to experience a broader adoption of phytosterols,” comments Patrick Veau, VP Health & Nutrition, Danisco.

“Danisco’s global presence and strong application know-how, combined with Arboris’ ability to supply high quality products, will ensure that no country needs to miss out on one of the most effective functional food ingredients to lower cholesterol.”

Peter Acton, COO Arboris adds, “As the leading manufacturer of pine-derived sterols, our focus is on providing a high quality, sustainable and dependable supply of sterols. Working with Danisco, a leading ingredient supplier, enables us to combine our expertise and secure sustained growth and recognition within phytosterols”.

The global phytosterol market, currently estimated at more than USD 300 million and growing an annual 7-9%, will receive a significant boost through this agreement due to the complementary capabilities of the two companies. Arboris’ large-scale production and integrated access to pine tall oil, the key raw material, will provide Danisco with high-purity free and esterified phytosterols.

The phytosterols produced by Arboris are also derived from a more stable raw material source compared to the alternative phytosterol raw material – soy deodorised distillate – ensuring sustainable growth opportunities. Danisco, with its global presence, application excellence and ability to understand local customer needs, will brand and market free and esterified phytosterols.

Danisco will launch the new phytosterol range in May 2011. The ingredient group will become an integral part of Danisco’s cardiovascular health platform. Danisco has six health and nutrition platforms in all.